title: Botulinum toxin treatment of cephalalgia alopecia increases substance P and calcitonin gene-related peptide-containing cutaneous nerves in scalp.
authors.affiliation: Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN, USA. cutrer.michael@mayo.edu
authors.forename: F M
authors.initials: FM
authors.lastname: Cutrer
authors.forename: P
authors.initials: P
authors.lastname: Sandroni
authors.forename: G
authors.initials: G
authors.lastname: Wendelschafer-Crabb
mesh_terms: D000505:Alopecia / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D015740:Calcitonin Gene-Related Peptide / Q000187:drug effects* / Q000378:metabolism; D015550:Cell Degranulation / Q000187:drug effects; D005260:Female; D018859:Hair Follicle / Q000187:drug effects / Q000294:innervation / Q000473:pathology; D006261:Headache / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D008407:Mast Cells / Q000187:drug effects; D018613:Microscopy, Confocal; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D012535:Scalp / Q000187:drug effects / Q000294:innervation / Q000473:pathology; D013373:Substance P / Q000187:drug effects* / Q000378:metabolism
chemical_list: D009465:Neuromuscular Agents; D013373:Substance P; D019274:Botulinum Toxins, Type A; D015740:Calcitonin Gene-Related Peptide